Skip to main content

Advertisement

Log in

Is serum S100B protein an useful biomarker in migraine?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Experimental data have demonstrated a role for S100B protein through the release of proinflammatory cytokines, following trigeminal nerve activation, implicated in the pathology of migraine. We investigated serum levels of S100B protein, as a peripheral glial biomarker, in patients with migraine. In total, 49 migraineurs and 35 age- and gender-matched controls were enrolled in this prospective clinical study. The migraine diagnosis was made according to the International Classification of Headache Disorders II diagnostic criteria. Serum samples were obtained for the measurement of S100B levels from all participants and were analyzed using commercial enzyme-linked immunosorbent assay kits. Serum S100B levels were significantly lower in migraineurs than controls (p < 0.001). S100B levels did not significantly differ in migraineurs with or without aura (p > 0.05). In addition, there was no correlation between serum S100B levels and headache characteristics, including attack severity, frequency and duration, and disease duration (p > 0.05). These findings suggest that serum S100B levels were significantly decreased in migraine patients, but further research is needed to ascertain the contribution of S100B in the clinical evaluation of migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5:43. doi:10.1186/1744-8069-5-43

    Article  PubMed Central  PubMed  Google Scholar 

  2. Russo A, Tessitore A, Giordano A, Salemi F, Tedeschi G (2012) The pain in migraine beyond the pain of migraine. Neurol Sci 33(Suppl 1):S103–S106. doi:10.1007/s10072-012-1052-7

    Article  PubMed  Google Scholar 

  3. Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL (2007) Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47(7):1008–1023. doi:10.1111/j.1526-4610.2007.00854.x Discussion 1024–1005

    Article  PubMed Central  PubMed  Google Scholar 

  4. Dublin P, Hanani M (2007) Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun 21(5):592–598. doi:10.1016/j.bbi.2006.11.011

    Article  CAS  PubMed  Google Scholar 

  5. Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32. doi:10.1016/j.brainres.2007.12.028

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Seiler K, Nusser JI, Lennerz JK, Neuhuber WL, Messlinger K (2013) Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment. J Headache Pain 14(1):74. doi:10.1186/1129-2377-14-74

    Article  PubMed Central  PubMed  Google Scholar 

  7. Feistel S, Albrecht S, Messlinger K (2013) The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion. J Headache Pain 14(1):93. doi:10.1186/1129-2377-14-93

    Article  PubMed Central  PubMed  Google Scholar 

  8. Dieterle A, Fischer MJ, Link AS, Neuhuber WL, Messlinger K (2011) Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor. Cephalalgia 31(1):31–42. doi:10.1177/0333102410375725

    Article  PubMed  Google Scholar 

  9. Negro A, Lionetto L, Simmaco M, Martelletti P (2012) CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs 21(6):807–818. doi:10.1517/13543784.2012.681044

    Article  CAS  PubMed  Google Scholar 

  10. Nagy AJ, Rapoport AM (2013) Update on future headache treatments. Neurol Sci 34(Suppl 1):S101–S108. doi:10.1007/s10072-013-1396-7

    PubMed  Google Scholar 

  11. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I (2009) S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793(6):1008–1022. doi:10.1016/j.bbamcr.2008.11.009

    Article  CAS  PubMed  Google Scholar 

  12. Papandreou O, Soldatou A, Tsitsika A, Kariyannis C, Papandreou T, Zachariadi A, Papassotiriou I, Chrousos GP (2005) Serum S100 beta protein in children with acute recurrent headache: a potentially useful marker for migraine. Headache 45(10):1313–1316. doi:10.1111/j.1526-4610.2005.00263.x

    Article  PubMed  Google Scholar 

  13. Teepker M, Munk K, Mylius V, Haag A, Moller JC, Oertel WH, Schepelmann K (2009) Serum concentrations of s100b and NSE in migraine. Headache 49(2):245–252. doi:10.1111/j.1526-4610.2008.01228.x

    Article  PubMed  Google Scholar 

  14. Yilmaz N, Karaali K, Ozdem S, Turkay M, Unal A, Dora B (2011) Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration? Cell Mol Neurobiol 31(4):579–585. doi:10.1007/s10571-011-9651-z

    Article  CAS  PubMed  Google Scholar 

  15. Torelli P, Beghi E, Manzoni GC (2004) Appendix to the international classification of headache disorders (2nd edition): application of diagnostic criteria for tension-type headache. Cephalalgia Int J Headache 24(9):791

    Google Scholar 

  16. Azapagasi E, Alehan F, Saygi S, Bayraktar N, Yazici AC (2012) Serum concentrations of neuron-specific enolase in pediatric migraine. Turk J Pediatr 54(2):150–155

    PubMed  Google Scholar 

  17. Guldiken S, Guldiken B, Demir M, Kabayel L, Ozkan H, Turgut N, Hunkar R, Kat S (2011) Soluble CD40 ligand and prolactin levels in migraine patients during interictal period. J Headache Pain 12(3):355–360. doi:10.1007/s10194-011-0306-8

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453

    Article  CAS  PubMed  Google Scholar 

  19. Portela LV, Brenol JC, Walz R, Bianchin M, Tort AB, Canabarro UP, Beheregaray S, Marasca JA, Xavier RM, Neto EC, Goncalves CA, Souza DO (2002) Serum S100B levels in patients with lupus erythematosus: preliminary observation. Clin Diagn Lab Immunol 9(1):164–166

    PubMed Central  PubMed  Google Scholar 

  20. Bartosik-Psujek H, Psujek M, Jaworski J, Stelmasiak Z (2011) Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurol Scand 123(4):252–256. doi:10.1111/j.1600-0404.2010.01393.x

    Article  CAS  PubMed  Google Scholar 

  21. Schaf DV, Tort AB, Fricke D, Schestatsky P, Portela LV, Souza DO, Rieder CR (2005) S100B and NSE serum levels in patients with Parkinson’s disease. Parkinsonism Relat Disord 11(1):39–43. doi:10.1016/j.parkreldis.2004.07.002

    Article  PubMed  Google Scholar 

  22. Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall’Igna O, Mazzini GS, Souza DO, Portela LV (2010) Serum levels of S100B and NSE proteins in Alzheimer’s disease patients. J Neuroinflammation 7:6. doi:10.1186/1742-2094-7-6

    Article  PubMed Central  PubMed  Google Scholar 

  23. Sorci G, Riuzzi F, Arcuri C, Tubaro C, Bianchi R, Giambanco I, Donato R (2013) S100B protein in tissue development, repair and regeneration. World J Biol Chem 4(1):1–12. doi:10.4331/wjbc.v4.i1.1

    Article  PubMed Central  PubMed  Google Scholar 

  24. Bianchi R, Adami C, Giambanco I, Donato R (2007) S100B binding to RAGE in microglia stimulates COX-2 expression. J Leukoc Biol 81(1):108–118. doi:10.1189/jlb.0306198

    Article  CAS  PubMed  Google Scholar 

  25. Li YK, Barger SW, Liu L, Mrak RE, Griffin WST (2000) S100 beta induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem 74(1):143–150

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Bruno PP, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 11(4):245–248

    CAS  PubMed  Google Scholar 

  27. Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, Lejeune F, Group EM (2001) On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int J Cancer 94(4):586–590

    Article  Google Scholar 

  28. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200–207. doi:10.1111/j.1526-4610.2006.00337.x

    Article  PubMed  Google Scholar 

  29. Alhazzani A, Goddeau RP (2013) Migraine and stroke: a continuum of association in adults. Headache 53(6):1023–1027. doi:10.1111/Head.12115

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asuman Celikbilek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celikbilek, A., Sabah, S., Tanik, N. et al. Is serum S100B protein an useful biomarker in migraine?. Neurol Sci 35, 1197–1201 (2014). https://doi.org/10.1007/s10072-014-1679-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1679-7

Keywords

Navigation